GOVX:NASDAQ
Geovax Labs Inc
$0.46
arrow_downward
-0.54%(-0.0025) 1D
$0.48
arrow_upward
+3.67% (+0.017)bedtimeAfter hours
Closed: Sep 11, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GOVX...
Open
$0.48
High
$0.49
Low
$0.45
Mkt. cap
3.38M
Avg. vol.
925.42K
Volume
126.48K
52-wk high
$18.20
52-wk low
$0.45
EPS
-$13.92
Beta
3.66
Shares outstanding
9.09M
No. of employees
19
Open
$0.48
High
$0.49
Low
$0.45
Mkt. cap
3.38M
Avg. vol.
925.42K
Volume
126.48K
52-wk high
$18.20
52-wk low
$0.45
EPS
-$13.92
Beta
3.66
Shares outstanding
9.09M
No. of employees
19
Profile
GeoVax is a clinical-stage biotechnology company which develops vaccines. GeoVax's development platform uses Modified Vaccinia Ankara vector technology, with improvements to antigen design and manufacturing capabilities. GeoVax uses recombinant DNA or recombinant viruses to produce virus-like particles in the person being vaccinated. Wikipedia
About Geovax Labs Inc
CEODavid A. Dodd
Employees19
Founded1988
HeadquartersAtlanta, Georgia, United States
SectorBiotechnology
Websitegeovax.com